| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |